US EditionTrump signs executive order slashing prescription drug costs by up to 80%
- On Monday, President Donald Trump signed a directive aimed at reducing prescription drug prices by aligning U.S. Costs with the lowest prices paid internationally.
- Trump launched this plan amid ongoing high drug prices in the U.S., repeating a previous attempt blocked by legal challenges and criticizing foreign governments and pharmaceutical companies.
- The order requires drugmakers to voluntarily reduce prescription drug prices within one month or face new government-imposed pricing limits, with Health Secretary Robert F. Kennedy Jr. Responsible for negotiating or enforcing these prices.
- Trump claimed the plan could cut drug prices by at least 59 percent and save trillions of dollars, while the pharmaceutical lobby warned it could reduce treatments and investments in America.
- Experts say immediate relief for insured Americans is unlikely, and the order may face legal and practical hurdles, leaving the long-term impact on drug prices uncertain.
648 Articles
648 Articles
Drug Price Executive Order Unleashes Unlikely Critics - Liberty Nation News
By John Klar President Donald Trump issued an executive order (EO) yesterday, May 12, designed to reduce drug prices for American patients and taxpayers alike. The move is a moderate effort to work amicably with pharmaceutical companies to cut taxpayer costs for Medicare and Medicaid, shave price gouging by middlemen, and usher in bipartisan “equity” for American consumers. […]
RFK Jr. to Newsmax: Trump Pharma Order Due to European Price-Fixing
Health and Human Services Secretary Robert F. Kennedy Jr. told Newsmax on Monday that the impetus behind President Donald Trump’s executive order to reduce prescription drug costs for Americans was price-fixing by European nations. Kennedy said Americans account for 75% of pharmaceutical company revenue but are just 4.2% of the world’s population. The result: Americans are paying more for prescription drugs than the rest of the world. “It’s not …
Coverage Details
Bias Distribution
- 49% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
